Axeda Systems Inc. (NASDAQ: XEDA), a provider of Device Relationship Management (DRM) software and services, today announced that Beckman Coulter, Inc. (NYSE: BEC) has chosen to employ the Axeda DRM system on its COULTER® LH 700 hematology line, a series of high-volume analyzers used by diagnostic laboratories to perform routine and emergency blood cell counts.
The Axeda DRM system enables Web transmission of instrument data - such as temperature, voltage, calibration and other events - and alerts service representatives if an instrument is operating outside preset performance standards, which can indicate a potential problem and result in equipment downtime. Beckman Coulter will incorporate the technology as part of its PROService program, the company's automated monitoring and proactive troubleshooting service for increased instrument uptime.
"Beckman Coulter is rated the leading hematology service provider by hospital laboratories, and now our service program is even better," said Denny Kershner, Beckman Coulter director of marketing. "The Axeda system increases our abilities to monitor events and troubleshoot potential problems. Customers enrolled in our PROService program will benefit from improved instrument uptime and performance, while Beckman Coulter will benefit from access to critical performance information in real-time, which enables us to lower our costs by reducing the number of unscheduled service visits."
This is the second application by Beckman Coulter of the Axeda DRM system. In July 2001, the company began implementing the Axeda DRM system on its SYNCHRON LX® clinical systems, one of the most widely placed chemistry analyzers in U.S. hospitals. The positive results of the DRM implementation on the chemistry system led Beckman Coulter to adopt the Axeda DRM system for use on its LH 700 series hematology instruments.
"Beckman Coulter is an innovator in remote diagnostic solutions and recognizes the benefits that Device Relationship Management technology brings to its offerings," said Paul Henderson, Axeda vice president of marketing. "We are delighted with this expansion of our relationship. We share a common vision and together we will enable leading-edge, proactive services that achieve maximum responsiveness and result in the highest levels of customer satisfaction."
Axeda Systems Inc. is an enterprise software and services company that helps businesses become more competitive by using the Internet to tap the value of real-time information to optimize their service, development, sales and manufacturing operations. The company's flagship Axeda Device Relationship Management System is a distributed software solution that lets businesses monitor, manage and service intelligent devices deployed at remote sites. Axeda serves Global 2000 companies in multiple markets including Industrial and Building Automation, Technology, Medical Instrumentation, Office and Semiconductor Equipment industries through sales and service offices in the US, Europe, Israel and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com .
The intelligent devices that we see and interact with everyday such as copiers, elevators, vending machines, building control units, medical devices, and even automobiles represent an important new source of business information. To date most enterprises have not been able to tap this information. Device Relationship Management addresses this significant information blind spot by providing a distributed information management system that leverages the Internet to allow timely, accurate, and unbiased information to be communicated automatically between devices deployed at customer facilities and external service personnel or enterprise business systems. Device Relationship Management helps turn reactive businesses into proactive businesses providing new sources of revenue and increased operational efficiency at lower costs.
Beckman Coulter, Inc. is a global biomedical company headquartered in Fullerton, Calif. The company develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical testing continuum. Through pioneering medical research and drug discovery, specialty testing, and patient care diagnostics, Beckman Coulter supports all phases of the battle against disease. Annual sales for the company totaled $2 billion in 2001, with 62% of this amount generated by recurring revenue from supplies, chemistry kits and services. For more information, visit www.beckmancoulter.com .
Press Contact:
Erin Nolan Smith
Corporate
+1 508-718-6351
enolan@axeda.com
